ArticleJournal of cheminformatics2025
The evolution of open science in cheminformatics: a journey from closed systems to collaborative innovation.
Article in Journal of cheminformatics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- IRACEMA: A Database Management System for Bioactive Compounds Obtained and Characterized by Brazilian Researchers.ACS omega · 2026Article
- Open-Source Molecular Docking and AI-Augmented Structure-Based Drug Design: Current Workflows, Challenges, and Opportunities.International journal of molecular sciences · 2026Review
- FAIR and Effective Communication of Data on Chemical Contaminant Biotransformation in the Environment.Environmental science & technology letters · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cheminformatics has significantly transformed over the past four decades, evolving from a field dominated by proprietary systems to one increasingly embracing open science principles. In its early years, cheminformatics was characterised by commercial software and restricted data access, limiting collaboration and reproducibility. The advent of open-source software in the late 1990s and early 2000s, including tools such as the Chemistry Development Kit (CDK) and RDKit, played a crucial role in democratising computational chemistry. Open data initiatives, such as PubChem and NMRShiftDB, further enhanced accessibility by providing freely available chemical information, fostering transparency and interoperability and introducing key standards, such as the International Chemical Identifier (InChI), revolutionised data integration and retrieval across diverse platforms. Community-driven efforts, including the Blue Obelisk movement and Open Notebook Science, have promoted open methodologies and collaborative research. More recently, national data infrastructure projects like NFDI4Chem have aimed to standardise research data management in cheminformatics, ensuring the long-term sustainability of open science practices. The increasing adoption of the FAIR (Findable, Accessible, Interoperable, Reusable) principles has further reinforced data sharing and reuse in computational chemistry. Challenges remain, particularly in overcoming resistance to data sharing and ensuring sustainable funding for open projects. However, the trajectory of cheminformatics demonstrates that embracing openness enhances scientific integrity and accelerates discovery and innovation.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.